HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yurika Otoki Selected Research

vinyl ether (divinyl ether)

11/2021Dietary Ethanolamine Plasmalogen Alleviates DSS-Induced Colitis by Enhancing Colon Mucosa Integrity, Antioxidative Stress, and Anti-inflammatory Responses via Increased Ethanolamine Plasmalogen Molecular Species: Protective Role of Vinyl Ether Linkages.
2/2021Ethanolamine Plasmalogen Suppresses Apoptosis in Human Intestinal Tract Cells in Vitro by Attenuating Induced Inflammatory Stress.
1/2021Dietary PlsEtn Ameliorates Colon Mucosa Inflammatory Stress and ACF in DMH-Induced Colon Carcinogenesis Mice: Protective Role of Vinyl Ether Linkage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yurika Otoki Research Topics

Disease

4Ischemia
01/2022 - 01/2017
3Inflammation (Inflammations)
01/2022 - 01/2017
3Hypercapnia
01/2022 - 01/2019
2Neoplasms (Cancer)
01/2022 - 02/2018
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 02/2016
2Neurodegenerative Diseases (Neurodegenerative Disease)
02/2017 - 02/2016
2Seasonal Affective Disorder
01/2017 - 01/2017
2Major Depressive Disorder (Major Depressive Disorders)
01/2017 - 01/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Alcoholic Fatty Liver
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Postmortem Changes (Adipocere)
01/2022
1Colitis
11/2021
1Colonic Neoplasms (Colon Cancer)
02/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2021
1Aberrant Crypt Foci
01/2021
1Carcinogenesis
01/2021
1Brain Diseases (Brain Disorder)
01/2021
1Brain Injuries (Brain Injury)
01/2017
1Neuroblastoma
02/2016
1Starvation
02/2016
1Osteoporosis
01/2015
1Bone Resorption
01/2015

Drug/Important Bio-Agent (IBA)

5LipidsIBA
01/2022 - 01/2017
3Ethanolamine (Colamine)IBA
11/2021 - 02/2016
3vinyl ether (divinyl ether)IBA
11/2021 - 01/2021
3Fatty Acids (Saturated Fatty Acids)IBA
01/2020 - 01/2017
3OxylipinsIBA
01/2020 - 01/2017
2phosphatidal ethanolaminesIBA
01/2022 - 11/2021
2PlasmalogensIBA
01/2022 - 01/2021
2choline plasmalogensIBA
01/2022 - 02/2017
2Glycerophospholipids (Phosphoglycerides)IBA
11/2021 - 02/2016
2Phospholipids (Phosphatides)FDA LinkGeneric
01/2021 - 01/2017
2stearic acid (magnesium stearate)FDA LinkGeneric
01/2021 - 01/2017
2Docosahexaenoic AcidsIBA
01/2020 - 01/2017
2Triglycerides (Triacylglycerol)IBA
01/2020 - 01/2017
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2017 - 01/2017
1lysoplasmalogenase (alkenylglycerophosphocholine hydrolase)IBA
01/2022
1SugarsIBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1Ethanol (Ethyl Alcohol)IBA
01/2022
1Amino AcidsFDA Link
01/2022
1AntioxidantsIBA
01/2022
1Choline (Choline Chloride)IBA
01/2022
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2022
1gamma-Aminobutyric Acid (GABA)IBA
01/2022
1NucleotidesIBA
01/2022
1Phospholipases (Phospholipase)IBA
01/2022
1Phosphorylcholine (Phosphocholine)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2022
1Dextran SulfateIBA
11/2021
1Dimenhydrinate (DMH)FDA LinkGeneric
01/2021
11,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
01/2021
1Ether (Diethyl Ether)IBA
01/2021
1Arachidonic Acid (Vitamin F)IBA
01/2020
1Cholesterol Esters (Cholesteryl Esters)IBA
01/2020
1Epoxy Compounds (Epoxides)IBA
01/2020
1GenisteinIBA
02/2018
1Telomerase (Telomerase Reverse Transcriptase)IBA
02/2018
1alpha-Linolenic Acid (Linolenic Acid)IBA
01/2017
113-hydroxy-9,11-octadecadienoic acidIBA
01/2017
1phosphatidylethanolamineIBA
01/2017
1Linoleic Acid (Linoleate)IBA
01/2017
1Epoxide HydrolasesIBA
01/2017
19-tetradecenoic acidIBA
01/2017
1CytochromesIBA
01/2017
1Caspase 3 (Caspase-3)IBA
02/2016
1lipoarabinomannan (LAM)IBA
01/2015
1toddaculinIBA
01/2015

Therapy/Procedure

1Therapeutics
01/2015